112
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Process optimization of spray-dried fanhuncaoin powder for pulmonary drug delivery and its pharmacokinetic evaluation in rats

, , , & ORCID Icon
Pages 1357-1370 | Received 04 Sep 2017, Accepted 28 Feb 2018, Published online: 23 Mar 2018

References

  • Amaro MI, Tewes F, Gobbo O, et al. Formulation, stability and pharmacokinetics of sugar-based salmon calcitonin-loaded nanoporous/nanoparticulate microparticles (NPMPs) for inhalation. Int J Pharm. 2015;483:6–18.
  • Wu B, Lin WH, Gao HY, et al. Four new antibacterial constituents from Senecio cannabifolius. Pharm Biol. 2006;44:440–444.
  • Wu B, Wu LJ, Wang LQ. A new lactone from Senecio cannabifolius Less. J Asian Nat Prod Res. 2002;4:315–317.
  • Yang XB, Wang XB, Pan WS, et al. Optimization and characterization of dry powder of fanhuncaoin for inhalation based on selection of excipients. Chem Pharm Bull. 2011;59:929–937.
  • Sun JD, Wang XB, Jiang S, et al. Preventive effect of Senecio cannabifolius Less. II on perfluoroisobutylene inhalation-induced acute lung injury in rats. J Int Pharm Res. 2014;41:444–448.
  • Zhang YJ, Fan L, Xi RG, et al. Lethal concentration of perfluoroisobutylene induces acute lung injury in mice mediated via cytokine storm, oxidative stress and apoptosis. Inhal Toxicol. 2017;29:255–265.
  • Zhao GY, Wang XB, Xi RG, et al. Protective effect of Senecio cannabifolius Less. II on acute lung injury induced by perfluoroisobutylene in mice. Pharm J Chin PLA. 2013;29:13–16.
  • Lacerda L, Parize AL, Favere V, et al. Development and evaluation of pH-sensitive sodium alginate/chitosan microparticles containing the antituberculosis drug rifampicin. Mat Sci Eng C-Mater. 2014;39:161–167.
  • Li HY, Birchall J. Chitosan-modified dry powder formulations for pulmonary gene delivery. Pharm Res. 2006;23:941–950.
  • Ungaro F, De Rosa G, Miro A, et al. Cyclodextrins in the production of large porous particles: development of dry powders for the sustained release of insulin to the lungs. Eur J Pharm Sci. 2006;28:423–432.
  • Cerchiara T, Luppi B, Chidichimo G, et al. Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems. Eur J Pharm Biopharm. 2005;61:195–200.
  • Gavini E, Hegge AB, Rassu G, et al. Nasal administration of Carbamazepine using chitosan microspheres: in vitro/in vivo studies. Int J Pharm. 2006;307:9–15.
  • Chew NYK, Shekunov BY, Tong HHY, et al. Effect of amino acids on the dispersion of disodium cromoglycate powders. J Pharm Sci-US. 2005;94:2289–2300.
  • Gao J, Ding XY, Chu C, et al. Dry powder inhalations containing thymopentin and its immunomodulating effects in Wistar rats. Eur J Pharm Sci. 2009;36:572–579.
  • Rabbani NR, Seville PC. The influence of formulation components on the aerosolisation properties of spray-dried powders. J Control Release. 2005;110:130–140.
  • Danhaive O, Chapin C, Horneman H, et al. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B. Pediatr Res. 2015;77:340–346.
  • Cuvelier B, Eloy P, Loira-Pastoriza C, et al. Minimal amounts of dipalmitoylphosphatidylcholine improve aerosol performance of spray-dried temocillin powders for inhalation. Int J Pharm. 2015;495:981–990.
  • Shishir MRI, Taip FS, Ab Aziz N, et al. Optimization of spray drying parameters for pink guava powder using RSM. Food Sci Biotechnol. 2016;25:461–468.
  • Learoyd TP, Burrows JL, French E, et al. Modified release of beclometasone dipropionate from chitosan-based spray-dried respirable powders. Powder Technol. 2008;187:231–238.
  • Li HY, Seville PC, Williamson IJ, et al. The use of amino acids to enhance the aerosolisation of spray-dried powders for pulmonary gene therapy. J Gene Med. 2005;7:343–353.
  • Muzaffar K, Kumar P. Parameter optimization for spray drying of tamarind pulp using response surface methodology. Powder Technol. 2015;279:179–184.
  • Abdel Messih HA, Ishak RA, Geneidi AS, et al. Nanoethosomes for transdermal delivery of tropisetron HCl: multi-factorial predictive modeling, characterization, and ex vivo skin permeation. Drug Dev Ind Pharm. 2017;43:958–971.
  • Mandal S, Mandal SD, Chuttani K, et al. Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model. Drug Dev Ind Pharm. 2016;42:1340–1350.
  • Witek-Krowiak A, Chojnacka K, Podstawczyk D, et al. Application of response surface methodology and artificial neural network methods in modelling and optimization of biosorption process. Bioresour Technol. 2014;160:150–160.
  • Hou JX, Zhang JC. Robust optimization of the efficient syngas fractions in entrained flow coal gasification using Taguchi method and response surface methodology. Int J Hydrogen Energ. 2017;42:4908–4921.
  • Li CB, Xiao QG, Tang Y, et al. A method integrating Taguchi, RSM and MOPSO to CNC machining parameters optimization for energy saving. J Clean Prod. 2016;135:263–275.
  • Hashemi SH, Montazer M, Naghdi N, et al. Formulation and characterization of alprazolam-loaded nanoliposomes: screening of process variables and optimizing characteristics using RSM. Drug Dev Ind Pharm. 2018;44:296–305.
  • Mahajan HS, Gundare SA. Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation. Carbohydr Polym. 2014;102:529–536.
  • Bosquillon C, Rouxhet PG, Ahimou F, et al. Aerosolization properties, surface composition and physical state of spray-dried protein powders. J Control Release. 2004;99:357–367.
  • Zhang Y, Wang XL, Lin X, et al. High azithromycin loading powders for inhalation and their in vivo evaluation in rats. Int J Pharm. 2010;395:205–214.
  • Li CX, Li CY, Liu ZS, et al. Enhancement in bioavailability of ketorolac tromethamine via intranasal in situ hydrogel based on poloxamer 407 and carrageenan. Int J Pharm. 2014;474:123–133.
  • Zhang WF, Chen XG, Li PW, et al. Chitosan and beta-cyclodextrin microspheres as pulmonary sustained delivery systems. J Wuhan Univ Technol-Mat Sci Edit. 2008;23:541–546.
  • Yang XB, Xi RG, Wang XB. Optimization for preparation process of Fanhuncaoin dry powder for inhalation. Chin Pharm J. 2016;51:1241–1244.
  • Chopra S, Motwani SK, Iqbal Z, et al. Optimisation of polyherbal gels for vaginal drug delivery by Box–Behnken statistical design. Eur J Pharm Biopharm. 2007;67:120–131.
  • Okamoto H, Aoki M, Danjo K. A novel apparatus for rat in vivo evaluation of dry powder formulations for pulmonary administration. J Pharm Sci. 2000;89:1028–1035.
  • Todo H, Iida K, Okamoto H, et al. Improvement of insulin absorption from intratracheally administrated dry powder prepared by supercritical carbon dioxide process. J Pharm Sci-US. 2003;92:2475–2486.
  • Couto RO, Martins FS, Chaul LT, et al. Spray drying of Eugenia dysenterica extract: effects of in-process parameters on product quality. Rev Bras Farmacogn. 2013;23:115–123.
  • Aho J, Van Renterghem J, Arnfast L, et al. The flow properties and presence of crystals in drug-polymer mixtures: rheological investigation combined with light microscopy. Int J Pharm. 2017;528:383–394.
  • Fan J, Dai Y, Shen H, et al. Application of soluplus to improve the flowability and dissolution of Baicalein phospholipid complex. Molecules. 2017;22:776–786.
  • Seville PC, Li HY, Learoyd TP. Spray-dried powders for pulmonary drug delivery. Crit Rev Ther Drug Carrier Syst. 2007;24:307–360.
  • Nijdam JJ, Langrish TAG. The effect of surface composition on the functional properties of milk powders. J Food Eng. 2006;77:919–925.
  • Tonon RV, Brabet C, Hubinger MD. Influence of process conditions on the physicochemical properties of acai (Euterpe oleraceae Mart.) powder produced by spray drying. J Food Eng. 2008;88:411–418.
  • Bosquillon C, Lombry C, Preat V, et al. Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance. J Control Release. 2001;70:329–339.
  • Mosen K, Backstrom K, Thalberg K, et al. Particle formation and capture during spray drying of inhalable particles. Pharm Dev Technol. 2004;9:409–417.
  • Esmaeili M, Aghajani M, Abbasalipourkabir R, et al. Budesonide-loaded solid lipid nanoparticles for pulmonary delivery: preparation, optimization, and aerodynamic behavior. Artif Cells Nanomed Biotechnol. 2016;44:1964–1971.
  • Jangam SV, Thorat BN. Optimization of spray drying of ginger extract. Dry Technol. 2010;28:1426–1434.
  • Hu LD, Zhang JL, Hu QF, et al. Microencapsulation of brucea javanica oil: characterization, stability and optimization of spray drying conditions. J Drug Deliv Sci Technol. 2016;36:46–54.
  • Li H, Nie SF, Yang XG, et al. Optimization of tocol emulsions for the intravenous delivery of clarithromycin. Int J Pharm. 2008;356:282–290.
  • Cai XS, Yang Y, Xie XY, et al. Preparation, characterization and pulmonary pharmacokinetics of a new inhalable zanamivir dry powder. Drug Deliv. 2016;23:1962–1971.
  • Carvalho SR, Watts AB, Peters JI, et al. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats. Eur J Pharm Biopharm. 2014;88:136–147.
  • Yang W, Johnston KP, Williams RO. Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm. 2010;75:33–41.
  • Rasenack N, Muller BW. Micron-size drug particles: common and novel micronization techniques. Pharm Dev Technol. 2004;9:1–13.
  • Yu CQ, Meng J, Chen J, et al. Preparation of ergoloid mesylate submicron emulsions for enhancing nasal absorption and reducing nasal ciliotoxicity. Int J Pharm. 2009;375:16–21.
  • Duret C, Merlos R, Wauthoz N, et al. Pharmacokinetic evaluation in mice of amorphous itraconazole-based dry powder formulations for inhalation with high bioavailability and extended lung retention. Eur J Pharm Biopharm. 2014;86:46–54.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.